NIH

October 2, 2014

Campaign seeks to bolster biosafety practices

Recent lapses in the handling of highly toxic and pathogenic materials at several federal laboratories have prompted the National Institutes of Health (NIH) to announce a new biosafety stewardship initiative.

September 26, 2014

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

September 25, 2014

A path to sarcoidosis treatment

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

September 18, 2014

Dioxin, fathers and preterm birth

Exposure of male mice to the pollutant dioxin causes preterm birth across multiple generations, suggesting that efforts to prevent preterm birth should include pre-conception interventions for dads.

September 16, 2014

Patient-derived stem cells shed light on pulmonary hypertension

Stem cells derived from patients with pulmonary arterial hypertension provide a unique resource for studying the molecular defects that cause the disease and testing potential therapies.

September 12, 2014

Schizophrenia ‘switches’ discovered

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.